Дженерик препарата "Reyataz" (атазанавир) компании "Ауробиндо Фарма" получил "предварительное одобрение" FDA
On January 31,2014, FDA granted tentative approval for a generic formulation of atazanavir sulfate capsules, 100 mg, 150 mg, 200 mg, and 300 mg, indicated for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV)-1 infection.
The ...
